The global formulation development outsourcing market is likely to register a CAGR of over 7.1% with an incremental growth of USD 8 billion during the forecast period 2022-2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global formulation development outsourcing market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the formulation development outsourcing industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the service, dosage form, application, end user, and region. The global market for formulation development outsourcing can be segmented by service: formulation optimization, pre-formulation services. Formulation development outsourcing market is further segmented by dosage form: inhaled, injectable, oral, topical, others. Based on application, the formulation development outsourcing market is segmented into: cardiovascular, genetic disorders, infectious diseases, neurology, oncology, respiratory, others. On the basis of end user, the formulation development outsourcing market also can be divided into: government and academic institutes, pharmaceutical and biopharmaceutical companies. Formulation development outsourcing market by region is categorized into: North America, Asia Pacific, Europe, Rest of the World (ROW).

By service:
– formulation optimization
– pre-formulation services

By dosage form:
– inhaled
– injectable
– oral
– topical
– others

By application:
– cardiovascular
– genetic disorders
– infectious diseases
– neurology
– oncology
– respiratory
– others

By end user:
– government and academic institutes
– pharmaceutical and biopharmaceutical companies

By region:
– North America
– Asia Pacific
– Europe
– Rest of the World (ROW)

The market research report covers the analysis of key stake holders of the global formulation development outsourcing market. Some of the leading players profiled in the report include Aizant Drug Research Solutions Private Limited, Biocon Limited (Syngene International Limited), Catalent Inc., Charles River Laboratories International Inc., Emergent BioSolutions Inc., Intertek Group plc, IRISYS LLC, Laboratory Corporation of America Holdings (LabCorp), Lonza Group AG, PCI Pharma Services, Inc. (PCI), Piramal Enterprises Ltd, Quotient Sciences Limited, Thermo Fisher Scientific Inc. (Patheon N.V.), among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global formulation development outsourcing market.
– To classify and forecast the global formulation development outsourcing market based on service, dosage form, application, end user, region.
– To identify drivers and challenges for the global formulation development outsourcing market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global formulation development outsourcing market.
– To identify and analyze the profile of leading players operating in the global formulation development outsourcing market.

Why Choose This Report
– Gain a reliable outlook of the global formulation development outsourcing market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.